The powerful imaging mass cytometry (IMC) has been used for the first time to examine the kidneys of patients with lupus (systemic lupus erythematosus), an autoimmune condition that can affect multiple organs and be fatal, and to identify lupus nephritis (LN) in those patients, according to
According to new research published in Blood Advances, early improvements in cardiac and hematologic parameters may predict better survival outcomes for patients being treated for stage IIIb AL amyloidosis, a deadly disease with a median survival of 4-6 months caused by abnormal protein buil
According to scientists, protein from two ounce-equivalents (oz-eq) of animal-based protein foods provides greater essential amino acids (EAA) bioavailability than an equal two oz-eq of plant-based protein foods.
Bacteria use a variety of methods to fight off the medications designed to destroy them. Ribosome-modifying enzymes are one of these weapons that are most common and these enzymes are becoming more widespread
Researchers have conducted an in-depth examination of the proteins responsible for cancer across a variety of tumour types, providing knowledge that cannot be determined only by genome sequencing
Researchers from UCLA and the Seattle Children's Research Institute worked together to advance our understanding of the genes governing the synthesis and release of immunoglobulin G, the most prevalent class of antibody in the human body.
“We have revealed a protein pathway that appears to have a direct impact on diseases, which opens up a new area for potential drug development,” says the study’s senior author Aurelio Lorico, MD PhD, Professor of Pathology and interim Chief Research Officer at Touro University Nevada College
According to a recent investigation, pathogenic bacteria exposed to the antibiotic albicidin rapidly improve their resistance by up to 1,000 times through a gene amplification process.
A high level of troponin, a protein typically used to rule out the possibility of a heart attack in patients with chest pain, may signal a higher risk of death from any cause within the next two years, according to research.
According to research published in the journal Heart, a high level of troponin, a protein typically used to rule out the possibility of a heart attack in patients with chest pain, may signal a higher risk of death from any cause within the next two years, even in the absence of known or susp
According to a UCLA study, a protein known as CEACAM1 helps protect the liver from damage during the transplantation process, which may improve the procedure's success.
A type of monoclonal antibody that has already been tested in cancer may be a viable treatment for amyotrophic lateral sclerosis, or ALS, a fatal neurological disease.